CClinicalTrials.gg
CompletedNCT01499615Updated Apr 9, 2015

A Prospective Study of a New Non-Invasive Cardiac Output Monitor in Children Undergoing General Anesthesia

An observational study in Children Receiving General Anesthesia, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 1 Hour to 18 Years. Per ClinicalTrials.gov, last updated 2015-04-09.

Sponsored by Massachusetts General Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
402
Ages
1 Hour to 18 Years
Sex
All
01

Study summary

Traditionally cardiac output has been estimated with thermodilution. Recently a new non-invasive device has been approved by the FDA for use in children of all ages including neonates (just 4 EKG electrodes). Primary outcome: To prospectively collect simultaneous physiologic data for all enrolled children by transferring the data from the investigators computerized anesthesia records to Excel spreadsheets and to correlate adverse events across monitoring devices.

Secondary outcomes: To determine if the device provides meaningful data in terms of an early warning of decreased cardiac output in specific subgroups of children undergoing surgery and anesthesia, e.g., neonates, trauma patients, children with congenital heart disease, those undergoing procedures with expected blood loss, those undergoing laparoscopic procedures where gas insufflation may impede venous return to the heart.

Read the detailed description

All children undergoing both elective and emergent surgery or GI endoscopy evaluation will be candidates for study. Since this is an FDA approved monitor that is approved across all age groups and since this is an additional monitor over those routinely used in the operating room and since it is noninvasive (4 EKG leads) verbal consent documented in the record has been approved by the IRB.

After informed verbal consent, either the research coordinator or a study physician will populate the cardiac output device with the child's age, weight, gender and height. For older children the required 4 EKG electrodes will be applied prior to induction of anesthesia (2 on the left side of the neck and 2 on the left chest at the level of the sternal depression; for neonates and infants one electrode can be applied to the forehead and the other to a thigh if application space is a problem). For children who are not able to be cooperative, as with most of our monitors the electrodes will be placed after induction of general anesthesia. An automated anesthesia record will continuously record heart rate, respiratory rate, oxygen saturation, systolic and diastolic pressures. The monitor will be set to perform these measurements every 1 minute. New software has been written that enables us to interface the cardiac output device with our automated anesthesia record. Thus the data from the cardiac output device will be inserted on the anesthesia record at approximate 1 minute intervals in real time. The data from the anesthesia records will later be downloaded as a unit to Excel spread sheets for later analysis. All demographic data will also be downloaded (age, weight, ASA physical status,surgical procedure) as well as blood loss and blood and fluid administered as well as drugs,significant intraoperative events, and the timing of events as they evolve. All data will be entered on a Partners password protected computer. Initially the patient's medical record number which links us to the electronic anesthesia record will be recorded as this allows us to download the data. Patient names will not be downloaded. Once the data set is completed,analyzed and locked, the medical record number will be removed so that no identifiers will remain. The data will not be shared with any other institution. Only deidentified data will remain on the final data base

02

Conditions studied

  • Children Receiving General Anesthesia

Keywords

  • adverse events
  • adverse cardiovascular events
  • early warning
03

In context

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.

Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Hour to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

neonates to teenagers

Inclusion criteria

  • All children presenting to our operating rooms for general anesthesia

Exclusion criteria

Exclusion Criteria:

  • Cardiac surgery, open chest procedures
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
402 participants (actual)

Groups and cohorts

  • children undergoing general anesthesia

    The intervention was the application of 4 ekg electrodes so as to non-invasivly measure cardiac output

    Device: cardiac monitor

Interventions

  • Devicecardiac monitor

    All children receive the same intervention which is the application of the 4 ekg electrodes

06

What researchers measure

Primary outcomes

  1. Correlate adverse cardiovascular events in children under anesthesia with the cardiac output device and standard anesthesia monitors

    We plan to record all physiologic data from approximately 400 children under anesthesia and correlate adverse cardiovascular events determined by this new cardiac output device with standard anesthesia monitors

    Time frame: approximately 18 months

Secondary outcomes

  1. determine if this device provides additonal safety for specific subgroups of pediatric patients under anesthesia e.g., those undergoing laparosopic procedures or procedures involving significant blood loss, neonates

    determine is some subgroups within the proposed 400 cases derive specific benefit from this additional non-invasive monitor, i.e., an early warning of impaired cardiac output or a correlation with decreased blood pressure with decreased cardiac output. The issue is whether cardiac out updated at approximate 20 second intervals can provide an eralier warning than the standard 3 to 5 minute blood pressures provided by non-invasive blood pressure monitroing which is the standard of care.

    Time frame: approximatley 18 months

07

Study locations

1 site
  • Operating rooms and GI endoscopy suites of the Massachusetts GeneralHospital
    Boston, Massachusetts 02114, United States
08

References and documents

Publications

  • August DA, Sui J, Cote CJ. Unintentional epidural injection of 88 mug.kg(-1) of epinephrine. Paediatr Anaesth. 2014 Nov;24(11):1185-7. doi: 10.1111/pan.12503. Epub 2014 Aug 11. PubMed 25130947 ↗
  • Cote CJ, Sui J, Anderson TA, Bhattacharya ST, Shank ES, Tuason PM, August DA, Zibaitis A, Firth PG, Fuzaylov G, Leeman MR, Mai CL, Roberts JD Jr. Continuous noninvasive cardiac output in children: is this the next generation of operating room monitors? Initial experience in 402 pediatric patients. Paediatr Anaesth. 2015 Feb;25(2):150-9. doi: 10.1111/pan.12441. Epub 2014 Jun 10. PubMed 24916144 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01499615
Lead sponsor
Massachusetts General Hospital
Responsible party
Charles Cote (Director of Clinical Research, Divisionof Pediatric Anesthesia, Massachusetts General Hospital) — Principal investigator
First posted
Dec 26, 2011
Start date
Jan 2012
Primary completion
Jan 2014
Completion
Jan 2014
Last update
Apr 9, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion